Market Cap 1.24B
Revenue (ttm) 168.63M
Net Income (ttm) 16.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 9.77%
Debt to Equity Ratio 0.00
Volume 244,188
Avg Vol 930,986
Day's Range N/A - N/A
Shares Out 121.55M
Stochastic %K 30%
Beta 1.22
Analysts Strong Sell
Price Target $15.62

Company Profile

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid t...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 7071 5397 0
Fax: 49 7071 5397 900
Address:
Paul-Ehrlich-Strasse 15, Tübingen, Germany
RemoteInvestor
RemoteInvestor Oct. 21 at 2:17 PM
$IMTX market realizing the content of yesterday's PR!
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 20 at 9:01 PM
$IMTX ESMO news! https://investors.immatics.com/news-releases/news-release-details/immatics-highlights-compelling-anti-tumor-activity-anzu-cel-0
0 · Reply
lukasgx
lukasgx Oct. 20 at 8:16 PM
$IMTX any PR based ESMO today presentation ?
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 17 at 1:43 PM
$IMTX I would not sell this right before ESMO in Berlin! BTW: Stop-losses are not a good idea...
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 17 at 1:38 PM
$IMTX up we go! Glad I have added. Life changing science!
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 17 at 12:07 PM
$IMTX "Sell the ESMO news" + bad market... I am considering adding. Any thoughts?
1 · Reply
RemoteInvestor
RemoteInvestor Oct. 15 at 7:47 PM
$IMTX at ESMO!
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 15 at 4:02 PM
$IMTX are we presenting at ESMO next week?
1 · Reply
RemoteInvestor
RemoteInvestor Oct. 15 at 12:48 PM
Binary event stocks! In crazy times with high volatility these are my biotech favs: $IMTX (oncology) $SLS (oncology) $VTGN (mental diseases)
0 · Reply
SaluteYourShorts
SaluteYourShorts Oct. 13 at 7:11 PM
$IMTX hmmm
0 · Reply
Latest News on IMTX
Immatics Appoints Amie Krause as Chief People Officer

Oct 27, 2025, 7:00 AM EDT - 7 hours ago

Immatics Appoints Amie Krause as Chief People Officer


Immatics: Multiple Clinical Catalysts In Q4'25 And 2026

Oct 10, 2025, 10:25 AM EDT - 17 days ago

Immatics: Multiple Clinical Catalysts In Q4'25 And 2026


Immatics N.V.: Trading Below Cash, But Not Without Reason

Mar 28, 2025, 1:02 PM EDT - 7 months ago

Immatics N.V.: Trading Below Cash, But Not Without Reason


Immatics: A Promising TCR Pipeline

Oct 11, 2024, 9:11 PM EDT - 1 year ago

Immatics: A Promising TCR Pipeline


Immatics Announces Pricing of $150 Million Public Offering

Oct 10, 2024, 8:50 PM EDT - 1 year ago

Immatics Announces Pricing of $150 Million Public Offering


Immatics Announces Proposed $150 Million Public Offering

Oct 10, 2024, 7:30 AM EDT - 1 year ago

Immatics Announces Proposed $150 Million Public Offering


Immatics Announces Pricing of $175 Million Public Offering

Jan 17, 2024, 8:30 PM EST - 1 year ago

Immatics Announces Pricing of $175 Million Public Offering


Immatics Announces Proposed Public Offering

Jan 17, 2024, 4:01 PM EST - 1 year ago

Immatics Announces Proposed Public Offering


Analyzing Immatics' Multi-Faceted Investment Case

Oct 9, 2023, 1:33 AM EDT - 2 years ago

Analyzing Immatics' Multi-Faceted Investment Case


Immatics shares rise on Moderna cancer collaboration

Sep 11, 2023, 8:59 AM EDT - 2 years ago

Immatics shares rise on Moderna cancer collaboration

MRNA


Moderna, Immatics to work jointly on cancer vaccines

Sep 11, 2023, 7:32 AM EDT - 2 years ago

Moderna, Immatics to work jointly on cancer vaccines

MRNA


Immatics Is Increasingly Becoming Interesting

Jul 24, 2023, 10:00 AM EDT - 2 years ago

Immatics Is Increasingly Becoming Interesting


RemoteInvestor
RemoteInvestor Oct. 21 at 2:17 PM
$IMTX market realizing the content of yesterday's PR!
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 20 at 9:01 PM
$IMTX ESMO news! https://investors.immatics.com/news-releases/news-release-details/immatics-highlights-compelling-anti-tumor-activity-anzu-cel-0
0 · Reply
lukasgx
lukasgx Oct. 20 at 8:16 PM
$IMTX any PR based ESMO today presentation ?
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 17 at 1:43 PM
$IMTX I would not sell this right before ESMO in Berlin! BTW: Stop-losses are not a good idea...
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 17 at 1:38 PM
$IMTX up we go! Glad I have added. Life changing science!
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 17 at 12:07 PM
$IMTX "Sell the ESMO news" + bad market... I am considering adding. Any thoughts?
1 · Reply
RemoteInvestor
RemoteInvestor Oct. 15 at 7:47 PM
$IMTX at ESMO!
0 · Reply
RemoteInvestor
RemoteInvestor Oct. 15 at 4:02 PM
$IMTX are we presenting at ESMO next week?
1 · Reply
RemoteInvestor
RemoteInvestor Oct. 15 at 12:48 PM
Binary event stocks! In crazy times with high volatility these are my biotech favs: $IMTX (oncology) $SLS (oncology) $VTGN (mental diseases)
0 · Reply
SaluteYourShorts
SaluteYourShorts Oct. 13 at 7:11 PM
$IMTX hmmm
0 · Reply
ScrotusMagnum
ScrotusMagnum Oct. 13 at 3:50 PM
$APLX $IMTX $SPY in case you haven’t noticed, $WTI is in play. Its probably going to be halted with these 30% moves. CEO bought $5 M worth of shares last week in the open market. Buy WTI stock and WTI crude – both will be enormously profitable eventually.
0 · Reply
Biotech_Beast
Biotech_Beast Oct. 10 at 2:32 PM
$IMTX Has multiple readouts in Q4'25, including data at ESMO on October 20. The company's cell therapy has advantages over $IOVA's lifileucel, although only applies to 40-50% of advanced melanoma patients. https://seekingalpha.com/article/4829111-immatics-multiple-clinical-catalysts-in-q425-and-2026
1 · Reply
estatebuyersmia
estatebuyersmia Oct. 9 at 10:33 PM
$FBIO $IMTX THANK YOU CHATGPT
1 · Reply
BobBijawklah
BobBijawklah Oct. 9 at 7:21 PM
$IMTX gladi bought this at 5 and change sold half of my position rest is free and clear should have bought more. Looks like its going to be aquired if i had to guess. Probably 15-20 dollar range.
0 · Reply
OhioTrader
OhioTrader Oct. 9 at 1:29 AM
$IMTX scorched earth baby!
0 · Reply
JJPlus7
JJPlus7 Oct. 8 at 7:07 PM
What do you folks know about Immatics $IMTX ? It's made a nice run since 9/10 when it was sitting at $5.91
2 · Reply
Robin8877
Robin8877 Oct. 8 at 6:45 PM
$IMTX This one just keeps on going! I should have bought more.
1 · Reply
RemoteInvestor
RemoteInvestor Oct. 8 at 5:32 PM
$IMTX great move over 10$ today! No obvious news... Still driven by new M&A CFO?
0 · Reply
OptionRunners
OptionRunners Oct. 8 at 4:19 PM
$IMTX Buyer of the January 16th 2026 $5/$15 call spreads 8,500 times for $5.20
0 · Reply
RunnerSignals
RunnerSignals Oct. 3 at 8:27 PM
Market Warriors Rise 💥 From red to green $RKLB $ARBE $HOUS $HUM $IMTX showed the fighting spirit today!
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 2 at 1:49 PM
$IMTX Excellent article that nails exactly where IMTX stands right now. So if you want to update your IMTX knowledge or get acquainted with IMTX, this is a must read. https://beyondspx.com/quote/IMTX/analysis/immatics-precision-oncology-unlocking-solid-tumor-potential-with-tcr-engineered-therapies-nasdaq-imtx
2 · Reply
RamenLives
RamenLives Oct. 1 at 5:35 PM
$IMTX Just curious, if a BO happens, what is a reasonable expectation of share price? IMO $30 seem about right.
2 · Reply